{
    "Trade/Device Name(s)": [
        "Chemtrue\u00ae Drug Screen Fentanyl/Tramadol Cup Test",
        "Chemtrue\u00ae Drug Screen Fentanyl/Tramadol Dip Card Test",
        "Chemtrue\u00ae Multi-Panel Drug Screen Cup Test",
        "Chemtrue\u00ae Multi-Panel Drug Screen Dip Card Test"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "K232736",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153192",
        "K142396"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DKZ",
        "DIS",
        "JXM",
        "DIO",
        "DJC",
        "LDJ",
        "LAF",
        "DJR",
        "DNK",
        "LCM",
        "JXN",
        "LFG"
    ],
    "Summary Letter Date": "November 16, 2023",
    "Summary Letter Received Date": "November 17, 2023",
    "Submission Date": "September 06, 2023",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3100",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3870",
        "21CFR862.3620",
        "21CFR862.3640",
        "21CFR862.3700",
        "21CFR862.3910"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Amphetamine Test System",
        "Barbiturates Test System",
        "Benzodiazepines Test System",
        "Cocaine and metabolites Test System",
        "Methamphetamine Test System",
        "Cannabinoids Test System",
        "Methadone Test System",
        "Morphine Test System",
        "Propoxyphene Test System",
        "Tricyclic antidepressant drugs test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Norfentanyl",
        "Tramadol",
        "Amphetamine",
        "Barbiturates",
        "Benzodiazepines",
        "Buprenorphine",
        "Cocaine",
        "Ecstasy",
        "Marijuana",
        "Methamphetamine",
        "Methadone",
        "Morphine",
        "Opiates",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Tricyclic Antidepressants"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Colloidal gold-based competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Test",
        "Dip Card",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtrue lateral flow immunoassays for qualitative detection of multiple drugs of abuse in human urine using cup and dip card formats",
    "Indications for Use Summary": "Rapid lateral flow immunoassays for qualitative detection of multiple drugs of abuse (including Norfentanyl, Tramadol, Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Ecstasy, Marijuana, Methamphetamine, Methadone, Morphine, Opiates, Oxycodone, Phencyclidine, Propoxyphene, Tricyclic Antidepressants) in human urine; intended for in vitro diagnostic use only; results are preliminary and require confirmatory testing.",
    "fda_folder": "Toxicology"
}